SWOT Analysis-Style Panel Discussion – Topics to be Addressed:

Time: 9:00 am
day: Day One


  • What have we learnt from recent industry developments?
  • What are the implications for R&D and the wider industry?
  • What are the strengths and differentiators of antigen-specific immunotherapies compared to other approaches?
  • What is the market opportunity and untapped clinical areas/unmet patient clinical need that holds most promise when it comes to antigen-specific immune tolerance inducing-therapies?
  • How have competing drug modalities reached late-stage clinical testing and what are the bottlenecks holding back the antigen-specific immune tolerance space back from clinical success?